Previous Close | 1.0000 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 4.8000 |
Strike | 350.00 |
Expire Date | 2024-09-20 |
Day's Range | 0.1000 - 1.0000 |
Contract Range | N/A |
Volume | |
Open Interest | 20 |
On June 12, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares of the company.
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $475.79, signifying a -1.19% move from its prior day's close.
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.